» Articles » PMID: 10886587

Increased Risk of Hip Fracture Among Patients with End-stage Renal Disease

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2000 Jul 8
PMID 10886587
Citations 307
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although patients with end-stage renal disease (ESRD) are at increased risk for bone loss, the risk of hip fracture in this population is not known. We compared the risk of hip fracture among dialysis patients with the general population.

Methods: We used data from the United States Renal Data System (USRDS) to identify all new Caucasian dialysis patients who began dialysis between January 1, 1989, and December 31, 1996. All hip fractures occurring during this time period were ascertained. The observed number of hip fractures was compared with the expected number based on the experience of residents of Olmstead County (MN, USA). Standardized incidence ratios were calculated as the ratio between observed and expected. The risk attributable to ESRD was calculated as the difference between the observed and expected rate of hip fracture per 1000 person-years.

Results: The number of dialysis patients was 326,464 (55.9% male and 44.1% female). There were 6542 hip fractures observed during the follow-up period of 643, 831 patient years. The overall incidence of hip fracture was 7.45 per 1000 person years for males and 13.63 per 1000 person years for females. The overall relative risk for hip fracture was 4.44 (95% CI, 4.16 to 4.75) for male dialysis patients and 4.40 (95% CI, 4.17 to 4.64) for female dialysis patients compared with people of the same sex in the general population. While the age-specific relative risk of hip fracture was highest in the youngest age groups, the added risks of fracture associated with dialysis rose steadily with increasing age. The relative risk of hip fracture increased as time since first dialysis increased.

Conclusions: The overall risk of hip fracture among Caucasian patients with ESRD is considerably higher than in the general population, independent of age and gender.

Citing Articles

Calcium-sensing receptor genetic variants and their association with CKD-MBD in South Indian Tamils.

Priyadarshini G, Dhinesh A, Parameswaran S, Sahoo J, Selvarajan S, Rajappa M J Appl Genet. 2025; .

PMID: 40085338 DOI: 10.1007/s13353-025-00955-7.


Orthopaedic fracture site and wound healing risk among end-stage renal disease patients undergoing open reduction internal fixation: A database analysis.

Hanna G, Tischler E, Mastrokostas P, Mesimer M, Bryk E, Pipitone P J Clin Orthop Trauma. 2025; 63:102946.

PMID: 40051461 PMC: 11880590. DOI: 10.1016/j.jcot.2025.102946.


Efficacy of Alfacalcidol Versus Calcitriol in Managing Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease.

El Nekidy W, Ghazal I, Mallat J, Abidi E, Malik A, Madhyastha R Hosp Pharm. 2025; :00185787251322428.

PMID: 40026490 PMC: 11869228. DOI: 10.1177/00185787251322428.


Construction and validation of a predictive model for the risk of osteoporosis in patients with chronic kidney disease based on NHANES data.

She C, Liu H PLoS One. 2025; 20(2):e0316494.

PMID: 39913394 PMC: 11801546. DOI: 10.1371/journal.pone.0316494.


Fracture in Association with Anticoagulant Therapy in Patients with CKD and Atrial Fibrillation.

Khan N, Kim S, Lee S, Bykov K, Paik J Clin J Am Soc Nephrol. 2024; 20(1):31-38.

PMID: 39665574 PMC: 11737451. DOI: 10.2215/CJN.0000000578.